These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 11188981)
1. The biochemistry of botulinum toxin type B. Setler P Neurology; 2000; 55(12 Suppl 5):S22-8. PubMed ID: 11188981 [TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin type B: an overview of its biochemistry and preclinical pharmacology. Callaway JE; Arezzo JC; Grethlein AJ Semin Cutan Med Surg; 2001 Jun; 20(2):127-36. PubMed ID: 11474745 [TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin type B (Myobloc): pharmacology and biochemistry. Callaway JE Clin Dermatol; 2004; 22(1):23-8. PubMed ID: 15158541 [TBL] [Abstract][Full Text] [Related]
4. The safety and efficacy of botulinum toxin type B in the treatment of patients with cervical dystonia: summary of three controlled clinical trials. Lew MF; Brashear A; Factor S Neurology; 2000; 55(12 Suppl 5):S29-35. PubMed ID: 11188982 [TBL] [Abstract][Full Text] [Related]
6. [Structure and function of botulinum toxin]. Fujii N Hokkaido Igaku Zasshi; 1995 Jan; 70(1):19-28. PubMed ID: 7744367 [TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin type B: an overview of its biochemistry and preclinical pharmacology. Callaway JE; Arezzo JC; Grethlein AJ Dis Mon; 2002 May; 48(5):367-83. PubMed ID: 12195266 [TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin-B and the management of hyperhidrosis. Baumann LS; Halem ML Clin Dermatol; 2004; 22(1):60-5. PubMed ID: 15158547 [TBL] [Abstract][Full Text] [Related]
9. Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosing. Lowe NJ; Yamauchi PS; Lask GP; Patnaik R; Moore D J Cosmet Laser Ther; 2002 Mar; 4(1):15-8. PubMed ID: 12079632 [TBL] [Abstract][Full Text] [Related]
10. [Molecular mechanism of action of tetanus toxin and botulinum neurotoxins]. Poulain B Pathol Biol (Paris); 1994 Feb; 42(2):173-82. PubMed ID: 7916455 [TBL] [Abstract][Full Text] [Related]
12. Commercial preparations and handling of botulinum toxin type A and type B. Parish JL Clin Dermatol; 2003; 21(6):481-4. PubMed ID: 14759580 [TBL] [Abstract][Full Text] [Related]
14. Revival of the use of botulinum toxin: application in dermatology. Böni R; Kreyden OP; Burg G Dermatology; 2000; 200(4):287-91. PubMed ID: 10894957 [TBL] [Abstract][Full Text] [Related]
15. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis]. Wissel J; Entner T Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048 [TBL] [Abstract][Full Text] [Related]
16. Botulinum toxins: pharmacology and its current therapeutic evidence for use. Panicker JN; Muthane UB Neurol India; 2003 Dec; 51(4):455-60. PubMed ID: 14742921 [TBL] [Abstract][Full Text] [Related]
17. Physiological effects of botulinum toxin in spasticity. Gracies JM Mov Disord; 2004 Mar; 19 Suppl 8():S120-8. PubMed ID: 15027064 [TBL] [Abstract][Full Text] [Related]
18. Anatomy of the sweat glands, pharmacology of botulinum toxin, and distinctive syndromes associated with hyperhidrosis. Kreyden OP; Scheidegger EP Clin Dermatol; 2004; 22(1):40-4. PubMed ID: 15158544 [TBL] [Abstract][Full Text] [Related]
19. Visual system side effects caused by parasympathetic dysfunction after botulinum toxin type B injections. Dubow J; Kim A; Leikin J; Cumpston K; Bryant S; Rezak M Mov Disord; 2005 Jul; 20(7):877-80. PubMed ID: 15806568 [TBL] [Abstract][Full Text] [Related]
20. [Botulism: structure and function of botulinum toxin and its clinical application]. Oguma K; Yamamoto Y; Suzuki T; Fatmawati NN; Fujita K Nihon Rinsho; 2012 Aug; 70(8):1329-37. PubMed ID: 22894067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]